Ban Flavored Cannabis Vapes and New Guidelines for Older Adults
The American Medical Association (AMA) has adopted two significant marijuana-related resolutions. That was during its recent House of Delegates meeting. One calling for a nationwide ban on flavored cannabis vaping products. And another recognizing both the potential therapeutic benefits and health risks of cannabis use among older adults.
These new measures add to the AMA's growing list of drug-policy stances. Which in recent years have included opposition to commercial marijuana legalization. Support for expunging cannabis-related criminal records. And endorsement of broad drug decriminalization.

Resolution #1: A Closer Look at Cannabis and Older Adults
The first resolution addresses the complex and often contradictory effects of marijuana on aging populations. It highlights two key observations:
- Risks: There is a "higher incidence of dementia among individuals who use cannabis."
- Benefits: Cannabis "may offer therapeutic benefits for managing agitation in dementia patients. Potentially serving as an alternative to antipsychotic medications."
Given the limited research focused specifically on this demographic. The AMA is calling for greater transparency and education. The adopted language includes two formal directives:
- RESOLVED, that the AMA support the development and publication of educational resources for clinicians. Including a virtual presentation that reviews the known effects of medical cannabis in older adults. Highlighting both potential benefits and risks.
- RESOLVED, that the AMA encourage expanded research into the therapeutic uses of cannabis in older adults. Particularly for managing agitation in individuals with cognitive impairment—as well as its possible adverse effects.

Resolution #2: Targeting Flavored Cannabis Vapes
The second resolution focuses on flavored cannabis vaping products. The AMA argues are designed to make the natural "strong, earthy, or even bitter taste" of cannabis more palatable. The organization warns that these flavorings have "increased adolescents’ willingness to try them."
In response, the AMA adopted a firm position:
- RESOLVED, that the AMA advocate and support a complete ban on the production, marketing, and sale of cannabis-based ECIG flavored devices and cartridges throughout all regulated cannabis dispensaries (medical and adult-use). Along with any outlet selling hemp products and public health entities.
- RESOLVED, that the AMA pursue legislative changes for a comprehensive ban on the production, marketing, and sale of cannabis-based ECIG flavored devices and cartridges in the United States.
Building on Existing AMA Drug Policies
These newly adopted resolutions are part of a broader and evolving AMA policy framework. In recent years, the organization has also:
- Endorsed broad drug decriminalization In 2024.
- In 2023: They advocated for psychedelics research. Opposed the criminalization of kratom. Called for an end to sentencing disparities between crack and powder cocaine. And supported the continued inclusion of marijuana metabolites in employment-based drug tests.
- In 2022: They voted to support the expungement of past cannabis convictions in states that have legalized the plant. While maintaining its opposition to full legalization.
Conclusion
With these dual resolutions, the AMA is navigating a careful balance. Acknowledging the medical promise of cannabis for certain aging patients. While pushing back against flavored products that appeal to younger populations. As research continues to evolve. The AMA's stance underscores the need for nuanced, evidence-based drug policy that weighs both public health and patient access.
The AMA's resolution to ban flavored cannabis vapes
This would likely have a significant and negative impact on vape factories. Though the exact outcome depends on the scope and enforcement of any resulting legislation. The main effects can be broken down into a few key areas:
Direct Impact: Loss of a Major Product Segment
Flavored cartridges represent a core and substantial part of the legal cannabis vape market. A ban would directly eliminate this product line for factories that produce them for the legal market. One industry source highlights that flavor variety is crucial for meeting consumer demand. And that restricting it would put legal vape manufacturers at a disadvantage compared to the illicit market, which would continue to offer flavored products. This would likely result in a significant loss of revenue and market share.
The Illicit Market Challenge
A recurring theme in the analysis of such bans is the risk of driving consumers toward unregulated, illicit products. There is information showing that "prohibiting the sale of disposable, battery-embedded vapor devices will not eliminate consumer demand. But merely shift sales to the unregulated and illicit market". This could lead to a two-tier system where legal factories suffer. While illegal operators and their suppliers thrive, ultimately undermining public health goals.
Regulatory Precedent and "Unintended Consequences"
The potential ban is part of a broader trend. For example, a similar measure proposed in California (AB 762) to ban disposable vapes. It has faced strong opposition from industry groups who warn it would devastate the legal cannabis industry by empowering illicit actors and reducing tax revenues.


All in one
AIR
EDGE
Canvas
Grid
Magix Nexo
VISTA
Pulse Pro
Ready S
Magix Cube
Slim
Cartridges
Base 2
Core S1
Batteries
Vape Filter










